The recording of human papillomavirus (HPV) vaccination in BIFAP primary care database: A validation study

Purpose In Spain, a human papillomavirus (HPV) vaccine was firstly marketed in 2006 and mainly administered in primary care (PC) practices for girls/women or schools. As for all vaccines, a valid data source is required for research on observational effectiveness or safety. The objective of this stu...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacoepidemiology and drug safety 2019-02, Vol.28 (2), p.201-208
Main Authors: Martín‐Merino, Elisa, Llorente‐García, Ana, Montero‐Corominas, Dolores, Huerta, Consuelo
Format: Article
Language:English
Subjects:
Adolescent
Adult
Child
Databases, Factual - statistics & numerical data
electronic health records
Electronic Health Records - statistics & numerical data
Female
health informatics systems
Human papillomavirus
human papillomavirus vaccination
Humans
Immunization
Immunization Schedule
Mass Vaccination - statistics & numerical data
Middle Aged
Papillomavirus Infections - epidemiology
Papillomavirus Infections - prevention & control
Papillomavirus Infections - virology
Papillomavirus Vaccines - administration & dosage
pharmacoepidemiology
Pharmacoepidemiology - methods
Pharmacoepidemiology - statistics & numerical data
Primary care
Primary Health Care - statistics & numerical data
Retrospective Studies
Spain - epidemiology
Uterine Cervical Neoplasms - epidemiology
Uterine Cervical Neoplasms - prevention & control
Uterine Cervical Neoplasms - virology
Vaccines
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose In Spain, a human papillomavirus (HPV) vaccine was firstly marketed in 2006 and mainly administered in primary care (PC) practices for girls/women or schools. As for all vaccines, a valid data source is required for research on observational effectiveness or safety. The objective of this study is to identify and validate HPV vaccinations recorded among women in The Primary Care Database For Pharmacoepidemiological Research (BIFAP) from 2007. Methods BIFAP includes a Vaccination File filled by PC practitionners and pediatricians. Information on women with HPV vaccinations recorded at any age was identified and validated according to whether (1) doses adhered to the following standard intervals: 27 to 269 days between first and second doses, >55 days between second and third doses, and
ISSN:1053-8569
1099-1557
DOI:10.1002/pds.4674